April 3, 2013
/PRNewswire/ -- Clinical trials are the cornerstone of getting biopharmaceuticals approved to treat diseases now and develop new medicines and knowledge for the future. Many people are unfamiliar with clinical trials until they or a loved one face a life-or-death disease diagnosis. Then the choices to treat their condition become more confusing and urgent. This is true even for professionals who work in and understand clinical trials. In Applied Clinical Trials magazine,
, PhD, Executive Director & Head, Clinical Operations, Vical Inc., and Research Scientist & Founder, Institute of Palliative Medicine & San Diego Hospice IRB, discusses her personal experience when her husband, Randy, is diagnosed with glioblastoma, an incurable brain cancer.
"It's hard to imagine anyone better suited to navigating the clinical trial process than I was. I have a doctorate in neurophysiology and I am the executive director and head of clinical operations at a biotechnology company where I have been conducting oncology research for years and currently manage a Phase III melanoma trial," writes Strause.
Only 3% to 5% of cancer patients participate in clinical trials, while oncology drug development projects account for 31% of all clinical trial projects worldwide. Now on the other side of her experiences – which surround her husband's subsequent death – Strause offers advice for the industry to change clinical trials by putting patients at the center of the clinical research enterprise.
"While the movement for patient-centric healthcare is growing, it has only started to be recognized as a better way to conduct clinical trials," says Applied Clinical Trials Content Director
. "The role of the patient is only going to grow in the next few years. While the content we offer is geared toward clinical trials professionals, and Linda's article offers concrete advice for those insiders, I believe the article can also help many others going through these difficult decisions."
For the full text of the article "Patient-First Approach to Improve Oncology Clinical Trials," visit
on our web site
Contact: Lisa Henderson Editorial Director
This press release was issued through eReleases® Press Release Distribution. For more information, visit
SOURCE Applied Clinical Trials